Literature DB >> 15653135

How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.

Giuseppe De Rosa1, Domenico Larobina, Maria Immacolata La Rotonda, Pellegrino Musto, Fabiana Quaglia, Francesca Ungaro.   

Abstract

The aim of this work was to study the influence of cyclodextrin (CD) incorporation on the properties of protein-loaded poly(lactide-co-glycolide) (PLGA) microspheres, with particular regards to protein release kinetics. To this purpose, insulin-loaded microspheres were prepared by spray-drying emulsion or solution formulations, with or without hydroxypropyl-beta-cyclodextrin (HPbetaCD), and fully characterized for encapsulation efficiency and release kinetics of both insulin and cyclodextrin. Homogeneous populations of spherical microparticles entrapping both insulin and HPbetaCD were obtained. In order to get an insight into insulin/HPbetaCD interactions occurring inside microspheres, Fourier transform infrared (FTIR) analysis in the Amide I region was performed. FTIR spectra of dried microspheres containing HPbetaCD showed a change in insulin secondary structure, attributed to the presence of insulin/HPbetaCD complexes within microspheres. Insulin release was affected by the presence of HPbetaCD depending on the initial formulation conditions. In the case of microspheres prepared from emulsion, cyclodextrin reduced only insulin burst, whereas in the case of microspheres obtained from solution, the overall insulin release rate was slowed down. Combining the release kinetics of HPbetaCD with the FTIR results on hydrated microspheres, it was concluded that the formation of insulin/HPbetaCD complexes inside microspheres is critical to decrease protein diffusivity in the polymer matrix and achieve an effective modulation of protein release rate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653135     DOI: 10.1016/j.jconrel.2004.09.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.

Authors:  Maite Estevan; Carlos Gamazo; Fernando Martínez-Galan; Juan M Irache
Journal:  AAPS PharmSciTech       Date:  2008-10-16       Impact factor: 3.246

Review 2.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

3.  PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).

Authors:  Vivek Gupta; Marauo Davis; Louisa J Hope-Weeks; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2011-04-06       Impact factor: 4.200

Review 4.  Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances.

Authors:  Fei Wu; Tuo Jin
Journal:  AAPS PharmSciTech       Date:  2008-12-16       Impact factor: 3.246

5.  Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.

Authors:  Estefanía Vega; M Antònia Egea; Ana Cristina Calpena; Marta Espina; M Luisa García
Journal:  Int J Nanomedicine       Date:  2012-03-09

6.  Improving the stability of insulin in solutions containing intestinal proteases in vitro.

Authors:  Liefeng Zhang; Hui Jiang; Wenjie Zhu; Lin Wu; Lingling Song; Qiuyan Wu; Yong Ren
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.